Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma

Oncotarget

Volumn 6, Issue 14, 2015, Pages 12710-12722

  Dai, Lu ^a,b   Cao, Yueyu ^a   Chen, Yihan ^a   Kaleeba, Johnan A R ^c   Zabaleta, Jovanny ^b   Qin, Zhiqiang ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Herpesvirus; KSHV; Lymphoma; Microarray; XCT

Indexed keywords

AMINO ACID TRANSPORTER; PROTEIN XCT; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; SLC7A11 PROTEIN, HUMAN;

AIDS RELATED COMPLEX; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TARGETING; GENE; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LOW DRUG DOSE; LYMPHOMA CELL LINE; OSGIN1 GENE; OXIDATIVE STRESS; PRIMARY EFFUSION LYMPHOMA; UNFOLDED PROTEIN RESPONSE; XRCC5 GENE; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

AMINO ACID TRANSPORT SYSTEM Y+; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOBLOTTING; LYMPHOMA, PRIMARY EFFUSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 84930038514     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3710     Document Type: Article

References (43)

1. Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995; 332:1186-1191.
2. Simonelli C, Spina M, Cinelli R, Talamini R, Tedeschi R, Gloghini A, Vaccher E, Carbone A and Tirelli U. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol. 2003; 21:3948-3954.
3. Chen YB, Rahemtullah A and Hochberg E. Primary effusion lymphoma. Oncologist. 2007; 12:569-576.
4. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S and Oksenhendler E. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005; 23:4372-4380.
5. Dai L, Cao Y, Chen Y, Parsons C and Qin Z. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J Hematol Oncol. 2014; 7:30.
6. Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem. 1986; 261:2256-2263.
7. Patel SA, Warren BA, Rhoderick JF and Bridges RJ. Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology. 2004; 46:273-284.
8. Gout PW, Buckley AR, Simms CR and Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)-cystine transporter: a new action for an old drug. Leukemia. 2001; 15:1633-1640.
9. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY and Sontheimer H. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci. 2005; 25:7101-7110.
10. Narang VS, Pauletti GM, Gout PW, Buckley DJ and Buckley AR. Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res. 2003; 23:4571-4579.
11. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR and Wang YZ. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate. 2007; 67:162-171.
12. Kaleeba JA and Berger EA. Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science. 2006; 311:1921-1924.
13. Veettil MV, Sadagopan S, Sharma-Walia N, Wang FZ, Raghu H, Varga L and Chandran B. Kaposi's sarcomaassociated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J Virol. 2008; 82:12126-12144.
14. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266:1865-1869.
15. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J and Parsons C. Upregulation of xCT by KSHVencoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 2010; 6:e1000742.
16. Qin Z, Dai L, Defee M, Findlay VJ, Watson DK, Toole BP, Cameron J, Peruzzi F, Kirkwood K and Parsons C. Kaposi's Sarcoma-Associated Herpesvirus Suppression of DUSP1 Facilitates Cellular Pathogenesis following De Novo Infection. J Virol. 2013; 87:621-635.
17. Bridges CC, Hu H, Miyauchi S, Siddaramappa UN, Ganapathy ME, Ignatowicz L, Maddox DM, Smith SB and Ganapathy V. Induction of cystine-glutamate transporter xc-by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2004; 45:2906-2914.
18. Sato H, Fujiwara K, Sagara J and Bannai S. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J. 1995; 310 :547-551.
19. Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, Mann GE and Bannai S. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biol Chem. 2001; 276:10407-10412.
20. Taguchi K, Tamba M, Bannai S and Sato H. Induction of cystine/glutamate transporter in bacterial lipopolysaccharide induced endotoxemia in mice. J Inflamm (Lond). 2007; 4:20.
21. Pozzesi N, Pierangeli S, Vacca C, Falchi L, Pettorossi V, Martelli MP, Thuy TT, Ninh PT, Liberati AM, Riccardi C, Sung TV and Delfino DV. Maesopsin 4-O-beta-Dglucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and upregulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia. J Chemother. 2011; 23:150-157.
22. Moon JS, Kim HE, Koh E, Park SH, Jin WJ, Park BW, Park SW and Kim KS. Kruppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer. J Biol Chem. 2011; 286:23808-23816.
23. Kim SH, Sierra RA, McGee DJ and Zabaleta J. Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori. BMC Microbiol. 2012; 12:175.
24. Huynh H, Ng CY, Ong CK, Lim KB and Chan TW. Cloning and characterization of a novel pregnancy-induced growth inhibitor in mammary gland. Endocrinology. 2001; 142:3607-3615.
25. Ong CK, Leong C, Tan PH, Van T and Huynh H. The role of 5' untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma. Oncogene. 2007; 26:1155-1165.
26. Liu M, Li Y, Chen L, Chan TH, Song Y, Fu L, Zeng TT, Dai YD, Zhu YH, Li Y, Chen J, Yuan YF and Guan XY. Allelespecific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. Gastroenterology. 2014; 146:1084-1096.
27. Ong CK, Ng CY, Leong C, Ng CP, Foo KT, Tan PH and Huynh H. Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem. 2004; 279:743-754.
28. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK and Cheng JQ. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem. 2004; 279:5405-5412.
29. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004; 4:181-189.
30. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87:245-313.
31. Featherstone C and Jackson SP. Ku, a DNA repair protein with multiple cellular functions?. Mutat Res. 1999; 434:3-15.
32. Grundy GJ, Moulding HA, Caldecott KW and Rulten SL. One ring to bring them all-the role of Ku in mammalian non-homologous end joining. DNA Repair (Amst). 2014; 17:30-38.
33. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC and Li GC. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996; 382:551-555.
34. Zhu C, Bogue MA, Lim DS, Hasty P and Roth DB. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 1996; 86:379-389.
35. Peraldo-Neia C, Cavalloni G, Soster M, Gammaitoni L, Marchio S, Sassi F, Trusolino L, Bertotti A, Medico E, Capussotti L, Aglietta M and Leone F. Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. BMC Cancer. 2014; 14:918.
36. Chen W, Hilton IB, Staudt MR, Burd CE and Dittmer DP. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma-associated Herpesvirus Lymphomas. J Virol. 2010; 84:3898-3908.
37. Santag S, Jager W, Karsten CB, Kati S, Pietrek M, Steinemann D, Sarek G, Ojala PM and Schulz TF. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells. Oncogene. 2013; 32:3676-3685.
38. Gottwein E and Cullen BR. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol. 2010; 84:5229-5237.
39. Wang T, Xia D, Li N, Wang C, Chen T, Wan T, Chen G and Cao X. Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis. J Biol Chem. 2005; 280:4374-4382.
40. Qin Z, Dai L, Bratoeva M, Slomiany MG, Toole BP and Parsons C. Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia. 2011; 25:1598-1609.
41. Huang Y, Dai Z, Barbacioru C and Sadee W. Cystineglutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 2005; 65:7446-7454.
42. Dai L, Trillo-Tinoco J, Bai L, Kang B, Xu Z, Wen X, Del Valle L and Qin Z. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL). PLoS One. 2014; 9:e90349.
43. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S and Knudsen S. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 2002; 3:research0048.